SEARCH RESULTS FOR: "Tag: VRTX"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2021(1)
2020(1)
2018(9)
2017(18)
2016(9)
2015(8)
2014(1)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(4)
Analyst Update(7)
Analyst Upgrades(2)
Best and Worst Stocks(6)
Buzz Stocks(8)
By the Numbers(2)
Editor's Pick(1)
Expectational Analysis(2)
Ezines(1)
General(2)
Indexes and ETFs(1)
Intraday Option Activity(4)
Investor Sentiment(1)
Market Recap(1)
Midday Market Check(2)
Opening View(3)
Options Recommendations(1)
Quantitative Analysis(6)
Stock Market News(4)
Stocks On the Move(3)
Technical Analysis(3)
VIX and Volatility(1)

6/11/2021 10:25 AM
The shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) are down 11.7% at $191.50 at last check, after the company announced an experimental drug it was developing to treat a rare genetic cond...
1/31/2020 10:53 AM
Earnings have been in focus all week on Wall Street, and that's continuing today, with a number of big names making notable moves after their quarterly reports. Leading the way of course is Amazon.co...
12/24/2018 11:43 AM
Crispr Therapeutics AG (NASDAQ:CRSP) is trading up 9.9% at $24.98 today, after it was revealed Friday evening that cystic fibrosis specialist Vertex Pharmaceuticals (VRTX) took a 10.1% stake in the ge...
11/1/2018 12:44 PM
Biotech name Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX) and medical device stock Boston Scientific Corporation (NYSE:BSX) both had subpar Octobers, pulling back amid the broader market sell-off. And...
10/18/2018 3:06 PM
Proteostasis Therapeutics (PTI) scored a big win after reporting positive data for its cystic fibrosis drug in an early stage study. In response, sector peer Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX...
 
Special Offers from Schaeffer's Trading Partners